Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02820727
Other study ID # AnTubingen-RV
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 2015
Est. completion date November 2016

Study information

Verified date June 2016
Source University Hospital Tuebingen
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study addresses the influence of anesthesia induction, ventilation and influence of cardiac surgical procedures and cardio-pulmonary-bypass on right ventricular function. Influence on patient outcome is also studied. Three dimensional echocardiography is applied.


Recruitment information / eligibility

Status Completed
Enrollment 59
Est. completion date November 2016
Est. primary completion date November 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

- informed consent given

- cardiac surgical procedure

- left sided cardiac surgery or bypass surgery, ascending aortic surgery, assist device implantation

Exclusion Criteria:

- pregnant patients

- contraindication for transesophageal echocardiography

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Germany University Hospital Tubingen Tubingen BW

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Tuebingen

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time on Intensive Care Unit (ICU) Duration of ICU stay up to 60 days
Secondary Time to hospital discharge Hospital Outcome up to 120 days
Secondary Catecholamine dosages after anesthesia induction, end of surgery, 12h and 24h after intensive care unit (ICU) admission up to 24 hours
Secondary Catecholamine free days Catecholamine free days on ICU up to 60 days
Secondary Hours on mechanical ventilation Duration of mechanical ventilation up to 1440 hours
Secondary Organ failure during ICU stay Early organ failure (Lab tests: Creatinine, Bilirubin, Lactate, Thromboplastin Time) up to 60 days
See also
  Status Clinical Trial Phase
Completed NCT04624412 - Different Intensities of Continuous Aerobic Exercises in Cardiac Rehab Phase 2 N/A
Completed NCT05563701 - Evaluation of the LVivo Image Quality Scoring (IQS)
Recruiting NCT04561908 - Transcatheter Microguidewire Drilling for Transseptal Left Atrial Access N/A
Active, not recruiting NCT06190743 - Perception of Cardiovascular Risk
Completed NCT04562636 - Evaluating a Messaging Campaign in the United States N/A
Completed NCT04580095 - Artificial Intelligence for Improved Echocardiography N/A
Recruiting NCT03277365 - MyGeneRank: A Digital Platform for Next-Generation Genetic Studies N/A
Active, not recruiting NCT05553106 - Evaluation of Cognitive Status, Kinesiophobia, Physical Activity Level, and Functional Performance in Coronary Intensive Care
Completed NCT03429920 - Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors N/A
Recruiting NCT04390672 - Multivessel TALENT N/A
Enrolling by invitation NCT03314818 - Natural History of Carotid Plaque as Determined by 3D Ultrasound N/A
Withdrawn NCT03289104 - Improving Sternal Healing After Cardiac Surgery: Sternal Wire vs ZIPFIX N/A
Completed NCT02917213 - Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction
Completed NCT02046902 - Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Completed NCT01909349 - Web-based Aftercare Intervention for Cardiac Patients N/A
Completed NCT01944254 - The Precision of Pulmonary Artery Cardiac Output-measurements in Spontaneously Breathing Patients N/A
Recruiting NCT01457586 - Hemoderivative Imputable Complications in Initial Uncomplicated Heart Surgery Phase 4
Recruiting NCT01541163 - Heart and Ischemic STrOke Relationship studY N/A
Recruiting NCT01207167 - Mediators of Atherosclerosis in South Asians Living in America
Completed NCT02645786 - Thyrotropin Over-suppression and Heart N/A